New research shows almost 90% of people in englands would agree to genetic testing to get the most effective medicine and reduce the risk of side effects. The study is Published in the QJM: An International Journal of Medicine,

Pharmacogenomics – An individual’s genetic response to medications – is an increase important strand of personalized health care but litle is Known about the public’s views on Researchers at Queen Mary University of London, Working with Key Partners, Have Carried Out A FIRST-OF-KIND Public Consultation to Gather the public’s Views on PHARMAGECOGETICS.

How a Person Responds to Medication is sometimes influenced by their genetic makeup. Some medicines do not work as well for people with certain gentic variations, and in other cases can lead to serial side effects. Side Effects Account for One in 16 Hospital Admissions and Have Been Estimated to Cost the nhs £ 2.2 billion annual – Deemonstruating how important pharmacoGENETIC TESTING COLD BE.

To gauge the public’s attitudes on pharmacogenetics, a research team, LED by Dr. Emma Magavern at Queen Maryn Mary University of London, in Collection with the National Center for Social Research (NATCEN), Surveyed a represcent sample of uk adults.

Dr. Magavern’s team worked with the NHS England Network of Excellence for Pharmacogenomics and Medicines Optimization and the Participant Panel at Genomics England. 2,719 Responses was obtained (a response rate of 58%)

Key findings from the survey include:

• Only Half of Participants Knew that variations in DNA Can Predict Eiter Efficiency or Side Effects from a Medication
• People who was prescribed medicine was almost twice as likely to want a pgx test
• Most People (59%) Reported Experience Eiter No Benefit or a Side Effect from a medicine.

Dr. Emma Magavern, Nihr Clinical Academic Lecturer in Queen Mary’s Center for Clinical Pharmacology and Precision Medicine WHO LED The Study, Said, Said, “This Survey Shows That Many Peeople In the UK FEELCH Have Taken Medication which has not been good for them, and most understand that people can respond different to the same medicine.

“There is Widespread Public Support for Personalizing Prscribing with Gentic Information and Including this within nhs clinical care nationally, in partnership with patients and height of appearance Agency. “

Dr. Rich Scott, Chief Executive Officer at Genomics England, SAID, “Pharmacogenomics holds enormous promise for improoving health and helping to shift care from reaction to prevention to prevention to the these Results show it’s vital that the public are partners, not passengers, on this journey.

“This study shows that the public welcome using genetic testing to help make drug prescriptions safer and more effective, and that people was able Want to be almost to As we develop the digital infrastructure and evidence on how routine use of pharmacogenomics could become a routine part of health care in the coming care and have a real impact on patient care. “

Dave McCormick, A Member of the Participant Panel at Genomics England, Said, “The Participant Panel was deleted to be involved in this important work. Encoured that patients are being involved from the outset. “